Company Phenom Platform continues its development and offers unique opportunities for investors and users.
The office headquarters of Phenom Platform is located at Second Floor, 6 Market Place, London, Fitzrovia, United Kingdom, W1W 8AF, emphasizing the company’s international status.
On the website www-phenom.ru, the company’s contact information is available, including the phone number +380 99 685 5299 and email address.
Investment Opportunities within Phenom Platform
Phenom Platform offers participation in a decentralized platform for utilizing smartphone resources in various operations, such as mining and data processing.
The official website of the company highlights the following project advantages:
-
Two years of experience in the investment field.
-
A proprietary token with a limited issuance of 100 million.
-
Development of proprietary applications for IOS and Android devices.
-
Over 40,000 active users.
-
Payout of over 2 million dollars as rewards.
-
Private 5th generation blockchain.
-
Payout of nearly 1.5 million dollars within the partnership program.
Reviews about Phenom Platform allow understanding the real cooperation opportunities and project advantages.
Phenom Token and Its Features
The Phenom token is backed by liquidity supported by various factors, including the Syntex project, data on application downloads and active users, as well as revenues from licenses and partnerships.
Technical requirements for project participation are also crucial: minimum Android version – 8.0 and above, minimum iOS version – 10.0 and above.
Account Funding and Withdrawal in Phenom Platform
The company offers convenient methods for account funding and withdrawal, with the main currency being USDT. Withdrawal fees are 15 USDT for amounts up to 750 USDT and 2% for amounts above 750 USDT, processing time – up to 48 hours on business days.
Conclusions
Before starting cooperation with Phenom Platform, it is important to review the information on the website, read real reviews, and consult with an expert to make an informed decision.